Navigation Links
Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients

ems Incorporated of New York in 1998. In Japan, Merck KGaA has co-exclusive marketing rights with ImClone Systems. Merck KGaA has an ongoing commitment to the advancement of oncology treatment and is currently investigating novel therapies in highly targeted areas, such as the use of Erbitux in colorectal cancer, squamous cell carcinoma of the head and neck and non-small cell lung cancer. Merck KGaA has also acquired the rights for the cancer treatment UFT® (tegafur-uracil) – an oral chemotherapy administered with folinic acid (FA) for the first-line treatment of metastatic colorectal cancer.

Merck KGaA is also investigating among other cancer treatments the use of Stimuvax® (formerly referred to as BLP25 Liposome Vaccine) in the treatment of non-small cell lung cancer. The vaccine was granted fast-track status in September 2004 by the FDA. Merck obtained the exclusive worldwide licensing rights from Biomira Inc. of Edmonton, Alberta, Canada, with the exception of Canada where the companies share rights.

References:

Parkin DM et al. CA Cancer J Clin 2005; 55: 72-108.
GLOBOCAN. http://www-dep.iarc.fr/
Argiris A et al. Cancer 2004; 101: 2222-2229.
Parkin DM et al. CA Cancer J Clin 2005; 55; 72-108.
GLOBOCAN. http://www-dep.iarc.fr/
Argiris A et al. Cancer 2004; 101: 2222-2229.


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.subscribe.merck.de to register online, change your selection or discontinue this service.

Merck is a global pharmaceutical and chemical company with sales of EUR 6.3 billion in 2006, a history that began in 1668, and a future shaped by 35,091 employees in 62 countries. Its success is characterized by
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
2. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
3. Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an Important Treatment Option for Patients With Metastatic Colorectal Cancer
4. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
5. Merck Serono Announces Presentation of Phase III Clinical Data on Safinamide in Parkinson’s Disease at the American Academy of Neurology 59th Annual Meeting
6. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
7. Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... antibodies for the treatment of autoimmune diseases, asthma and ... Yujiro S. Hata to its board of ... business and corporate development is a tremendous asset to ... and chief executive officer of Xencor. "Xencor faces a ...
(Date:7/30/2015)... 30, 2015 Edwards Lifesciences Corporation (NYSE: EW ... and hemodynamic monitoring, today announced that Robert A. Ingram ... "Bob is an ardent champion for innovation in the ... have him on Edwards, board as we pursue our focused ... and CEO.  "Bob has provided a valuable perspective to our ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 ... it will release its second quarter 2015 financial results ... 2015.   In conjunction with the release, the Company ... at 5:00 p.m. Eastern Time on ... of the quarter and other business developments. ...
Breaking Medicine Technology:Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... Northern Ireland, Dec. 20, 2010 HeartSine Technologies ... the 14th annual Aisling Awards ceremony, November 25th, in ... who has made significant contributions to Belfast and surrounding ... the Belfast Media Group in 1997 to ...
... Calif., Dec. 20, 2010 Huntsman Gay Global Capital, ... the completion of a recapitalization of Sunquest Information Systems® ... recapitalization, led by Huntsman Gay, was done in partnership ... since 2007 and is retaining a significant stake in ...
Cached Medicine Technology:HeartSine Technologies Wins 2010 Aisling Award for Outstanding Achievement in Business 2Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems 2Huntsman Gay-Led Consortium Completes Recapitalization of Sunquest Information Systems 3
(Date:7/31/2015)... ... 31, 2015 , ... Indosoft, Inc., is pleased to announce a major update ... their flagship contact center ACD system for Asterisk-based call centers . The new ... script components to the agent only when wanted, and allows for validation of data ...
(Date:7/31/2015)... Minneapolis, Minn. (PRWEB) , ... July 31, 2015 ... ... software, is selected as a contributor for LeadingAge’s Center for Aging Services Technologies ... studies designed to help long-term and post-acute care providers understand the benefits of ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Beaumont Hospital's Karmanos Center for Natural Birth . The Karmanos Center ... a safe natural childbirth experience. With nurses and caregivers that are trained in ...
(Date:7/31/2015)... ... 2015 , ... New Energy Works Timberframers invites the public to join their ... 2015 from 9am – 12pm. Timber frame raisings are special, celebrating both ... as the culmination of months of effort, planning, fundraising, and dreaming takes shape. ...
(Date:7/31/2015)... ... July 31, 2015 , ... An article entitled " Dentists ... a woman’s unfortunate experience having cosmetic skin procedures done by a family doctor ... blistering, swelling, bruising, and pain. This woman’s experience is only one in a ...
Breaking Medicine News(10 mins):Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3
... response has practical application, expert says , SUNDAY, Jan. 17 ... into why we miss things when they,re uncommon. , ... often don,t find it," said Jeremy Wolfe of Harvard Medical ... news release from Cell Press, which published a study on ...
... ... by advocating for physician patient relationships which ensure optimal patient care and well being, ... guidelines such as breast cancer screening that can negatively impact patients. , ... (PRWEB) January 17, 2010 -- ...
... The world-renowned wellness ... balm based on the timeless healing principles of ayurvedic medicine , ... Carlsbad, CA (PRWEB) January 17, 2010 -- Made ... this winter season. Adara Lip Balm heals dry, chapped lips with a signature blend of ...
... , - More relief goods, staff arrive, but challenges ... , - Agency reports "race against clock" to save lives ... , Jan. 16 World Vision relief ... a boost as relief goods began arriving in Haiti,s quake-ravaged capital city ...
... , ... Latin America , WASHINGTON , Jan. 16 ... Haiti relief efforts using a new Portuguese website called ... of American States announced. , AjudaPanamericana.org is the third language option ...
... , WASHINGTON , Jan. ... Development (USAID) Bureau for Global Health is sending additional specialists ... medical needs.  Reports indicate that thousands of individuals in makeshift ... Tuesday,s earthquake. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO ) , Global ...
Cached Medicine News:Health News:Southern Medical Association Takes Position on Breast Cancer Screening 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 3Health News:Southern Medical Association Takes Position on Breast Cancer Screening 4Health News:Pamper and Soothe Your Lips with the Chopra Center's New Adara Certified Organic Lip Balm 2Health News:HAITI QUAKE: World Vision Situation Update 2Health News:HAITI QUAKE: World Vision Situation Update 3Health News:HAITI QUAKE: World Vision Situation Update 4Health News:Haiti Relief Site Now in Portuguese 2Health News:Haiti Relief Site Now in Portuguese 3Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 3
... Further expanding the growing portfolio ... Pulse Oximeter is a compact, affordable ... advanced signal processing technology, it offers ... and is compatible with the complete ...
... of the revolutionary OxiMax® Pulse Oximetry ... combines Nellcor's best-in-class pulse oximetry with ... motion-tolerant OxiMax N-595 Pulse Oximeter is ... processing technology, which enables it to ...
The Model 900 is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring. It also incorporates an LCD waveform m...
The Model 340 is intended for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
Medicine Products: